期刊文献+

超声心动图技术在慢性肝病中的应用及研究进展

Application and Research Progress of Echocardiography in Chronic Liver Diseases
下载PDF
导出
摘要 慢性肝病以肝脏病变为基础,逐渐影响全身各个系统的功能,并可导致心脏血管功能变化,早已发现肝硬化患者存在静息性心动过速、肢体远端温暖、脉压差增大、毛细血管搏动征等高血流动力循环的表现。慢性肝病的心血管主要并发症为:(1)肝硬化性心肌病;(2)肝肺综合征;(3)门脉性肺动脉高压。超声心动图是评估慢性肝病患者心血管功能障碍的重要筛查方法。通过评估心脏收缩及舒张功能指标,评价肺内血管分流情况,估测肺动脉压力和右心功能改变等作出有效诊断,且由于超声心动图非侵入性、实时快速成像和诊断准确率高等优点成为首选检查方法,为进一步诊治指明方向。 Chronic liver disease is based on liver disease,gradually affects the function of the whole body system,and can lead to changes in cardiac vascular function. Patients with cirrhosis have been found to have resting tachycardia, distal limb warmth, increased pulse pressure difference, and the capillaries beating sign is positive for the performance of a high blood flow regimen. The main cardiovascular complications of chronic liver disease are:(1) cirrhotic cardiomyopathy;(2) hepatopulmonary syndrome ;(3)portal hypertension. Echocardiography is an important screening method for assessing cardiovascular dysfunction in patients with chronic liver disease. By evaluating systolic and diastolic function indicators, evaluating pulmonary vascular shunt conditions, estimating pulmonary right heart function changes to make an effective diagnosis. Echocardiography has become the preferred method of its non-invasive, real-time rapid imaging and high diagnostic accuracy, and it indicates the direction for further diagnosis and treatment.
作者 袁帅 郑哲岚 YUAN Shuai;ZHENG Zhelan(Echocardiography and Vascular Ultrasound Center,The Hospital,College of Medicine,ZhUniversity,Hangzhou 310003,Zhejiang,China)
出处 《心血管病学进展》 CAS 2018年第3期312-316,共5页 Advances in Cardiovascular Diseases
基金 浙江省自然科学基金面上项目(LY17H180002)
关键词 超声心动图 慢性肝病 肝硬化性心肌病 肝肺综合征 门脉性肺动脉高压 Echocardiography Chornic liver disease Cirrhotic cardiomyopathy Hepatopulmonary syndrome Portopulmonary hypertension
  • 相关文献

参考文献2

二级参考文献13

  • 1SφrenMφller,JensHHenriksen.Cardiopulmonary,complications in chronic liver disease[J].World Journal of Gastroenterology,2006,12(4):526-538. 被引量:17
  • 2SeyedAliGaskari,SamuelSLee.Cardiac and vascular changes in cirrhosis:Pathogenic mechanisms[J].World Journal of Gastroenterology,2006,12(6):837-842. 被引量:33
  • 3Pere Ginès,Juan Uriz,Blas Calahorra,Guadalupe Garcia–Tsao,Patrick S. Kamath,Luis Ruiz Del Arbol,Ramón Planas,Jaime Bosch,Vicente Arroyo,Juan Rodés.Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis[J].Gastroenterology.2002(6)
  • 4S?ren M?ller,Jens H. Henriksen.Cirrhotic cardiomyopathy[J].Journal of Hepatology.2010(1)
  • 5Antonio Figueiredo,Francisco Romero-Bermejo,Rui Perdigoto,Paulo Marcelino,Mark T. Keegan.The End-Organ Impairment in Liver Cirrhosis: Appointments for Critical Care[J].Critical Care Research and Practice.2012
  • 6T. Timoh,M.A. Protano,G. Wagman,M. Bloom,T.J. Vittorio.A Perspective on Cirrhotic Cardiomyopathy[J].Transplantation Proceedings.2011(5)
  • 7Moreshwar S. Desai,Shabier Zainuer,Curtis Kennedy,Debra Kearney,John Goss,Saul J. Karpen.Cardiac Structural and Functional Alterations in Infants and Children With Biliary Atresia, Listed for Liver Transplantation[J].Gastroenterology.2011(4)
  • 8William RFord,Stuart AHonan,RichardWhite,C RobinHiley.Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated hearts[J].British Journal of Pharmacology.2009(5)
  • 9Mireia Torregrosa,Santi Aguadé,Laura Dos,Rosa Segura,Antonio Gónzalez,Artur Evangelista,Joan Castell,Carlos Margarit,Rafael Esteban,Jaume Guardia,Joan Genescà.Cardiac alterations in cirrhosis: reversibility after liver transplantation[J].Journal of Hepatology.2004(1)
  • 10John M. McCurley,Stephen U. Hanlon,Shao-kui Wei,Erich F. Wedam,Michael Michalski,Mark C. Haigney.Furosemide and the progression of left ventricular dysfunction in experimental heart failure[J].Journal of the American College of Cardiology.2004(6)

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部